John W Jackson

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Allergic Rhinitis

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Hepatology communications

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra T Strauss, Carolyn N Sidoti, Hannah C Sung, Vedant S Jain, Harold Lehmann, Tanjala S Purnell, John W Jackson, Daniel Malinsky, James Peter Hamilton, Jacqueline M Garonzik Wang, Stephen H Gray, Macey L Levan, Jeremiah S Hinson, Ayse P Gurses, Ahmet Gürakar, Dorry L Segev, Scott Levin
Artificial intelligence-based clinical decision support for liver transplant evaluation and considerations about fairness: A qualitative study. Hepatology communications 7 (10) (2023)
Ayobami T Akenroye, Guohai Zhou, John W Jackson, Jodi B Segal, G Caleb Alexander, Sonal Singh
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy (2022)
Alexandra T Strauss, Carolyn N Sidoti, Tanjala S Purnell, Hannah C Sung, John W Jackson, Scott Levin, Vedant S Jain, Daniel Malinsky, Dorry L Segev, James Peter Hamilton, Jacqueline M Garonzik Wang, Stephen H Gray, Macey L Levan, Joseph R Scalea, Andrew M Cameron, Ahmet Gurakar, Ayse P Gurses
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 28 (12) (2022)
John W Jackson, Lisa Fulchino, James Rogers, Helen Mogun, Jennifer Polinski, David C Henderson, Sebastian Schneeweiss, Michael A Fischer
"Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients". Pharmacoepidemiology and drug safety 27 (1) (2017)